155 related articles for article (PubMed ID: 29154744)
1. Generation and characterization of a novel candidate gene therapy and vaccination vector based on human species D adenovirus type 56.
Duffy MR; Alonso-Padilla J; John L; Chandra N; Khan S; Ballmann MZ; Lipiec A; Heemskerk E; Custers J; Arnberg N; Havenga M; Baker AH; Lemckert A
J Gen Virol; 2018 Jan; 99(1):135-147. PubMed ID: 29154744
[TBL] [Abstract][Full Text] [Related]
2. Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product Development.
Ballmann MZ; Raus S; Engelhart R; Kaján GL; Beqqali A; Hadoke PWF; van der Zalm C; Papp T; John L; Khan S; Boedhoe S; Danskog K; Frängsmyr L; Custers J; Bakker WAM; van der Schaar HM; Arnberg N; Lemckert AAC; Havenga M; Baker AH
J Virol; 2021 Oct; 95(22):e0038721. PubMed ID: 34469243
[TBL] [Abstract][Full Text] [Related]
3. A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55.
Liu T; Zhou Z; Tian X; Liu W; Xu D; Fan Y; Liao J; Gu S; Li X; Zhou R
Vaccine; 2018 Apr; 36(16):2199-2206. PubMed ID: 29548605
[TBL] [Abstract][Full Text] [Related]
4. In Vitro and In Vivo Evaluation of Human Adenovirus Type 49 as a Vector for Therapeutic Applications.
Bates EA; Counsell JR; Alizert S; Baker AT; Suff N; Boyle A; Bradshaw AC; Waddington SN; Nicklin SA; Baker AH; Parker AL
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452348
[TBL] [Abstract][Full Text] [Related]
5. Recombinant influenza virus carrying human adenovirus epitopes elicits protective immunity in mice.
Yang P; Li T; Liu N; Gu H; Han L; Zhang P; Li Z; Wang Z; Zhang S; Wang X
Antiviral Res; 2015 Sep; 121():145-51. PubMed ID: 26112646
[TBL] [Abstract][Full Text] [Related]
6. Generation of neutralizing monoclonal antibodies against a conformational epitope of human adenovirus type 7 (HAdv-7) incorporated in capsid encoded in a HAdv-3-based vector.
Liu M; Tian X; Li X; Zhou Z; Li C; Zhou R
PLoS One; 2014; 9(7):e103058. PubMed ID: 25054273
[TBL] [Abstract][Full Text] [Related]
7. Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice.
Dicks MD; Spencer AJ; Coughlan L; Bauza K; Gilbert SC; Hill AV; Cottingham MG
Sci Rep; 2015 Nov; 5():16756. PubMed ID: 26576856
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae.
Chen H; Xiang ZQ; Li Y; Kurupati RK; Jia B; Bian A; Zhou DM; Hutnick N; Yuan S; Gray C; Serwanga J; Auma B; Kaleebu P; Zhou X; Betts MR; Ertl HC
J Virol; 2010 Oct; 84(20):10522-32. PubMed ID: 20686035
[TBL] [Abstract][Full Text] [Related]
9. Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: "Adenovirus Vaccine Within an Adenovirus Vector".
Yan Y; Jing S; Feng L; Zhang J; Zeng Z; Li M; Zhao S; Ou J; Lan W; Guan W; Wu X; Wu J; Seto D; Zhang Q
Virol Sin; 2021 Jun; 36(3):354-364. PubMed ID: 32458297
[TBL] [Abstract][Full Text] [Related]
10. Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions.
Qiu H; Li X; Tian X; Zhou Z; Xing K; Li H; Tang N; Liu W; Bai P; Zhou R
J Virol; 2012 Aug; 86(15):7964-75. PubMed ID: 22623776
[TBL] [Abstract][Full Text] [Related]
11. Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector.
Zhang Q; Su X; Seto D; Zheng BJ; Tian X; Sheng H; Li H; Wang Y; Zhou R
Vaccine; 2009 Feb; 27(8):1145-53. PubMed ID: 19146906
[TBL] [Abstract][Full Text] [Related]
12. The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species.
Dicks MD; Guzman E; Spencer AJ; Gilbert SC; Charleston B; Hill AV; Cottingham MG
Vaccine; 2015 Feb; 33(9):1121-8. PubMed ID: 25629523
[TBL] [Abstract][Full Text] [Related]
13. Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity.
Lemckert AAC; Grimbergen J; Smits S; Hartkoorn E; Holterman L; Berkhout B; Barouch DH; Vogels R; Quax P; Goudsmit J; Havenga MJE
J Gen Virol; 2006 Oct; 87(Pt 10):2891-2899. PubMed ID: 16963747
[TBL] [Abstract][Full Text] [Related]
14. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.
Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R
Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297
[TBL] [Abstract][Full Text] [Related]
15. Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies.
Wortmann A; Vöhringer S; Engler T; Corjon S; Schirmbeck R; Reimann J; Kochanek S; Kreppel F
Mol Ther; 2008 Jan; 16(1):154-62. PubMed ID: 17848961
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein.
Sumida SM; Truitt DM; Lemckert AA; Vogels R; Custers JH; Addo MM; Lockman S; Peter T; Peyerl FW; Kishko MG; Jackson SS; Gorgone DA; Lifton MA; Essex M; Walker BD; Goudsmit J; Havenga MJ; Barouch DH
J Immunol; 2005 Jun; 174(11):7179-85. PubMed ID: 15905562
[TBL] [Abstract][Full Text] [Related]
17. The Fiber Knob Protein of Human Adenovirus Type 49 Mediates Highly Efficient and Promiscuous Infection of Cancer Cell Lines Using a Novel Cell Entry Mechanism.
Baker AT; Davies JA; Bates EA; Moses E; Mundy RM; Marlow G; Cole DK; Bliss CM; Rizkallah PJ; Parker AL
J Virol; 2021 Jan; 95(4):. PubMed ID: 33268514
[TBL] [Abstract][Full Text] [Related]
18. Group B Streptococcus Induces a Robust IFN-γ Response by CD4(+) T Cells in an In Vitro and In Vivo Model.
Clarke D; Letendre C; Lecours MP; Lemire P; Galbas T; Thibodeau J; Segura M
J Immunol Res; 2016; 2016():5290604. PubMed ID: 26989699
[TBL] [Abstract][Full Text] [Related]
19. Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.
Sparer TE; Wynn SG; Clark DJ; Kaplan JM; Cardoza LM; Wadsworth SC; Smith AE; Gooding LR
J Virol; 1997 Mar; 71(3):2277-84. PubMed ID: 9032363
[TBL] [Abstract][Full Text] [Related]
20. Recombinant adenovirus vectors expressing interleukin-5 and -6 specifically enhance mucosal immunoglobulin A responses in the lung.
Braciak TA; Gallichan WS; Graham FL; Richards CD; Ramsay AJ; Rosenthal KL; Gauldie J
Immunology; 2000 Nov; 101(3):388-96. PubMed ID: 11106943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
